Matches in SemOpenAlex for { <https://semopenalex.org/work/W108044729> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W108044729 abstract "BACKGROUND: BNP is a cardiac peptide with vasodilatory, natriuretic and diuretic properties. Recent studies have suggested that its vasodilatory hypotensive properties may limit the renal actions of BNP, especially in patients with borderline low blood pressure. We have recently identified an alternatively spliced transcript for BNP (ASBNP) that includes a unique and distinct longer carboxyl-terminus consisting of 34 amino acids. Based upon preliminary studies, we generated a truncated form (ASBNP2.1) that contains the first 16 amino acids of the C-terminal of ASBNP. METHODS: We determined the cardiorenal and humoral actions of intravenous infusion of ASBNP2.1 at 2 pmol/Kg/min, 10 pmol/Kg/min and 100 pmol/Kg /min in 10 dogs with rapid ventricular pacing induced overt CHF (240 bpm for 10 days). * p<0.05 RESULTS: IV infusion of ASBNP 2.1 increased aquaresis (from 0.19±0.04 to 0.32±0.07, 0.46±0.11 and 0.39±0.09 ml/min*) without a significant change in urinary sodium excretion. Importantly, ASBNP 2.1 enhanced glomerular filtration rate (GFR), from 31±4 to 47±8, 69±10 and 56±9 ml/min*. These renal actions were associated with increases in urinary BNP*, ANP* and cGMP* excretion. BNP 2.1 did not have any systemic vasodilatory action resulting in no change in mean arterial blood pressure or cardiac-filling pressures even at the highest dose. There was not change in serum sodium concentration. CONCLUSION: We report for the first time that this novel peptide based upon ASBNP has potent aquaretic and GFR enhancing actions without the vasodilatory hypotensive properties in an experimental model of overt CHF. The lack of vasodilatation but with renal actions also suggest that the C-terminus plays a key role in the vascular actions of this peptide offering new insights into vascular-renal structure function of BNP and related peptides. This renal specific peptide may have potential therapeutic benefit in states of renal dysfunction with volume overload to enhance GFR and water excretion without the detrimental side effect of hypotension." @default.
- W108044729 created "2016-06-24" @default.
- W108044729 creator A5014193048 @default.
- W108044729 creator A5036359021 @default.
- W108044729 creator A5062156561 @default.
- W108044729 creator A5090322167 @default.
- W108044729 date "2007-10-16" @default.
- W108044729 modified "2023-10-17" @default.
- W108044729 title "Abstract 386: A Novel Aquaretic and Glomerular Filtration Rate Enhancing Peptide Without Vascular Vasodilatory Actions in Experimental CHF." @default.
- W108044729 doi "https://doi.org/10.1161/circ.116.suppl_16.ii_61-b" @default.
- W108044729 hasPublicationYear "2007" @default.
- W108044729 type Work @default.
- W108044729 sameAs 108044729 @default.
- W108044729 citedByCount "0" @default.
- W108044729 crossrefType "journal-article" @default.
- W108044729 hasAuthorship W108044729A5014193048 @default.
- W108044729 hasAuthorship W108044729A5036359021 @default.
- W108044729 hasAuthorship W108044729A5062156561 @default.
- W108044729 hasAuthorship W108044729A5090322167 @default.
- W108044729 hasConcept C10146269 @default.
- W108044729 hasConcept C120770815 @default.
- W108044729 hasConcept C126322002 @default.
- W108044729 hasConcept C134018914 @default.
- W108044729 hasConcept C159641895 @default.
- W108044729 hasConcept C164705383 @default.
- W108044729 hasConcept C174459258 @default.
- W108044729 hasConcept C2775915353 @default.
- W108044729 hasConcept C2778198053 @default.
- W108044729 hasConcept C2779918671 @default.
- W108044729 hasConcept C71924100 @default.
- W108044729 hasConcept C77411442 @default.
- W108044729 hasConcept C84393581 @default.
- W108044729 hasConceptScore W108044729C10146269 @default.
- W108044729 hasConceptScore W108044729C120770815 @default.
- W108044729 hasConceptScore W108044729C126322002 @default.
- W108044729 hasConceptScore W108044729C134018914 @default.
- W108044729 hasConceptScore W108044729C159641895 @default.
- W108044729 hasConceptScore W108044729C164705383 @default.
- W108044729 hasConceptScore W108044729C174459258 @default.
- W108044729 hasConceptScore W108044729C2775915353 @default.
- W108044729 hasConceptScore W108044729C2778198053 @default.
- W108044729 hasConceptScore W108044729C2779918671 @default.
- W108044729 hasConceptScore W108044729C71924100 @default.
- W108044729 hasConceptScore W108044729C77411442 @default.
- W108044729 hasConceptScore W108044729C84393581 @default.
- W108044729 hasIssue "suppl_16" @default.
- W108044729 hasLocation W1080447291 @default.
- W108044729 hasOpenAccess W108044729 @default.
- W108044729 hasPrimaryLocation W1080447291 @default.
- W108044729 hasRelatedWork W1980957264 @default.
- W108044729 hasRelatedWork W1990900710 @default.
- W108044729 hasRelatedWork W1993617885 @default.
- W108044729 hasRelatedWork W2002038679 @default.
- W108044729 hasRelatedWork W2021846613 @default.
- W108044729 hasRelatedWork W2050825966 @default.
- W108044729 hasRelatedWork W2125804349 @default.
- W108044729 hasRelatedWork W2212154849 @default.
- W108044729 hasRelatedWork W2283093578 @default.
- W108044729 hasRelatedWork W2473470765 @default.
- W108044729 hasVolume "116" @default.
- W108044729 isParatext "false" @default.
- W108044729 isRetracted "false" @default.
- W108044729 magId "108044729" @default.
- W108044729 workType "article" @default.